Krabbe Disease Global Patient Registry

Part of paid clinical trials in Buffalo, New York.

Sponsor
State University of New York at Buffalo
Study ID
NCT02993796
Status
Recruiting
Apply to this trial

Conditions

  • Krabbe Disease

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to develop a clinical database of individuals diagnosed with Krabbe disease in order to determine which symptoms herald the onset of clinical disease in the various phenotypes of Krabbe disease; to determine whether level of GALC enzyme activity, or a specific genetic mutation predict the clinical course; and to determine which neurodiagnostic tests predict onset and/or severity of the disease.

Key Dates

Start date
Sep 30, 2014
Status verified
Feb 2025
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
60 participants (estimated)

Primary Outcome Measure

Overall Survival [ Time Frame: up to 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
State University of New York at BuffaloBuffaloNew York14203
Thomas J. Langan, MD
[email protected]
716-888-4732

Find similar trials in Buffalo, NY

By research site
State University of New York at Buffalo· Buffalo, NY

Related Studies